For the year ended December 31, 2021, we had a net income of $1,345,808, which consisted of interest income on marketable securities held in the Trust Account of $4,341 and gain on the change in fair value of warrant liabilities of $1,980,000 offset by operating costs of $638,533.
Liquidity and Capital Resources
On July 28, 2020, we consummated the Initial Public Offering of 4,000,000 Units, generating gross proceeds of $40,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 260,000 Private Units to the Sponsor at a price of $10.00 per Private Unit generating gross proceeds of $2,600,000.
Following the Initial Public Offering and the sale of the Private Units, a total of $40,600,000 was placed in the Trust Account. We incurred $2,646,665 in transaction costs, including $1,000,000 of underwriting fees, $1,000,000 of deferred underwriting fees and $646,665 of other offering costs.
Our timeframe to complete the initial business combination expired on April 28, 2022. On April 20, 2022, we held an Annual General Meeting of Shareholders. Among other things, shareholders approved the proposal to extend the time to complete our initial business company by six monthly extensions to October 28, 2022. In connection with the vote to approve the Extension Amendment, the holders of 78,050 shares of the Company’s ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.46 per share, for an aggregate redemption amount of $816,101.13. As a result, an amount of $41,008,428.63 remained in the trust account.
On October 28, 2022, we held an Extraordinary General Meeting of Shareholders. Shareholders approved the proposal to extend the time to complete our initial business company by six monthly extension to April 28, 2023. In connection with the vote to approve the Extension Amendment, the holders of 3,311,198 shares of the Company’s ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.73 per share, for an aggregate redemption amount of $35,540,143.87. As a result, an amount of $6,555,395.97 remained in the trust account.
We held another Extraordinary Shareholder Meeting on April 25, 2023 for our shareholders to vote for the proposal to amend the Company’s amended and restated memorandum and articles of association to extend the date by which the Company has to consummate a business combination six (6) times for an additional one (1) month each time from April 28, 2023 to October 28, 2023 by amending the Amended and Restated Memorandum and Articles of Association by deleting the existing Section 48.7 thereof and replacing them with the new Section 48.7. Shareholders approved the proposal to extend the time to complete our initial business company by six monthly extension to October 28, 2023. The holders of 405,705 shares of the Company’s ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $11.18 per share, for an aggregate redemption amount of $4,535,353.71. As a result, an amount of $ 2,292,209.07 remained in the trust account.
For the year ended December 31, 2022, net cash used in operating activities was $406,551. Net income of $611,525 was impacted by interest earned on investments of $378,536 and a change in fair value of warrant liabilities of $886,866. Changes in operating assets and liabilities provided $247,326 of cash from operating activities.
For the year ended December 31, 2021, net cash used in operating activities was $381,390. Net income of $1,345,808 was impacted by interest earned on investments of $4,341 and a change in fair value of warrant liabilities of $1,980,000. Changes in operating assets and liabilities provided $257,143 of cash from operating activities.
At December 31, 2022 we had investments held in the Trust Account of $6,658,707. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account, excluding deferred underwriting commissions, to complete our Business Combination. We may withdraw interest earned from the Trust Account to pay taxes, if any. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete a Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.